The Tyrolean Founder MLH1 Variant c.836T>G Causes Lynch Syndrome Due to a Leaky Splice Effect
Biomolecules · 17.08.2026 · 16 (8) · 1200
DOI: 10.3390/biom16081200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 17.08.2026. Verfasst von Sukanya Horpaopan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, Medical University Innsbruck, 6020 Innsbruck, Austria. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, MutL Protein Homolog 1, Founder Effect, RNA Splicing. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Agency for Education and Internationalization, Ernst Mach-Grant of the Austrian Agency for Education and Internationalization.
Abstract (Originalsprache)
The identification of a pathogenic variant (PV) in one of the mismatch repair (MMR) genes confirms the diagnosis of Lynch syndrome (LS). Hence, the correct classification of MMR gene variants is of utmost importance for appropriate counselling, surveillance, and treatment of LS patients and their families. In 7/200 unrelated Tyrolean-suspected LS patients, we identified the rare variant MLH1:c.836T>G. Clinical and tumor data strongly indicate that this founder variant is associated with an increased risk for early-onset LS-associated tumors. We also demonstrate that the variant leads to aberrant mRNA splicing. However, the splice effect’s leakiness together with the small effect of the amino acid change p.(Val297Gly) encoded by the residual full-length transcripts in a functional assay preclude its formal classification as (likely) PV according to internationally accepted variant interpretation guidelines. The family histories of the carriers suggest that the obstacles to classify the variant as (likely) PV may be related with a reduced penetrance. Nonetheless, and despite the formal classification of MLH1:c.836T>G as a variant of uncertain significance, we show that carriers should undergo cancer surveillance and predictive testing should be offered to relatives. This variant illustrates the need for an improved classification framework for appropriate categorization of lower-penetrance alleles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Genetics, Medical University Innsbruck, 6020 Innsbruck, Austria.
- Department of Anatomy, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
- Department of Obstetrics and Gynecology, Medical University Innsbruck, 6020 Innsbruck, Austria.
- Tyrolpath Obrist Brunhuber GmbH, 6511 Zams, Austria.
ORCID-Profile: Sukanya Horpaopan, Esther Schamschula, Heidelinde Fiegl, Simon Schnaiter, Katharina Wimmer
Förderung
- Austrian Agency for Education and Internationalization
- Ernst Mach-Grant of the Austrian Agency for Education and Internationalization
Zitieren
APA
Horpaopan, S., Schamschula, E., Fiegl, H., Dapoz, H., Lutz-Nicoladoni, C., Schnaiter, S., Amberger, A., Strasser, U., Lunzer, R., von der Heidt, A., Csanaky, K., Zschocke, J., & Wimmer, K. (2026). The Tyrolean Founder MLH1 Variant c.836T>G Causes Lynch Syndrome Due to a Leaky Splice Effect. Biomolecules, 16(8), 1200. https://doi.org/10.3390/biom16081200
Vancouver
Horpaopan S, Schamschula E, Fiegl H, Dapoz H, Lutz-Nicoladoni C, Schnaiter S, et al. The Tyrolean Founder MLH1 Variant c.836T>G Causes Lynch Syndrome Due to a Leaky Splice Effect. Biomolecules. 2026;16(8):1200. doi:10.3390/biom16081200
BibTeX
@article{Horpaopan2026,
author = {Horpaopan, Sukanya and Schamschula, Esther and Fiegl, Heidelinde and Dapoz, Hannes and Lutz-Nicoladoni, Christina and Schnaiter, Simon and Amberger, Albert and Strasser, Ulrich and Lunzer, Renate and von der Heidt, Andreas and Csanaky, Katalin and Zschocke, Johannes and Wimmer, Katharina},
title = {The Tyrolean Founder MLH1 Variant c.836T>G Causes Lynch Syndrome Due to a Leaky Splice Effect},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {8},
pages = {1200},
doi = {10.3390/biom16081200}
}
EUVIMED